February 22, 2015
Alzheimer's Association congratulates Julianne Moore on her Best Actress Academy Award win
The Alzheimer's Association congratulates Julianne Moore on winning the Oscar for Best Actress at the 87th Annual Academy Awards. Playing the title character in the film "Still Alice," Moore’s poignant portrayal of a woman diagnosed with younger-onset Alzheimer's disease illustrates the impact of Alzheimer's, the sixth-leading cause of death in the United States, on individuals and their families.
February 22, 2015
Alzheimer's Association salutes Glen Campbell on his Academy Award nomination for Best Original Song
The Alzheimer's Association thanks and salutes Glen Campbell and Julian Raymond for the song "I'm Not Gonna Miss You," that was among the Academy Award nominees for Best Original Song, during the Oscar ceremony this evening. The Association also celebrates the dedication and devotion of the Campbell family, "Glen Campbell: I'll Be Me" documentary producers James Keach and Trevor Albert, the members of the Wrecking Crew who performed on the recording of "I'm Not Gonna Miss You," and Tim McGraw for his beautiful performance of the song in honor of Glen Campbell during the 87th Academy Awards.
February 17, 2015
Alzheimer's Association statement on People of the State of New York vs. Actavis and Forest Laboratories
As the leading voluntary health organization in Alzheimer's disease care, support and research, the Alzheimer’s Association has a long-held and firm belief that people with Alzheimer’s and other dementias should have affordable access to treatments available today as well as to prevention and effective treatments in the future.
February 11, 2015
Alzheimer's Association, Weston Brain Institute and Alzheimer's Research UK join forces to form initiative to fund vital brain disease research
Three leading research funders from the UK and North America have joined forces to launch a new global initiative called MEND, or MEchanisms of cellular death in NeuroDegeneration, with a fund of $1.25 million (£820,000/$1.56CDN) for targeted research into brain diseases that cause dementia, such as Alzheimer's.
February 5, 2015
The discovery of Alzheimer's disease treatment by 2025 will save the U.S. $220 billion within first five years
The United States could save $220 billion within the first five years of a treatment for Alzheimer's disease being introduced, according to a new report from the Alzheimer's Association.
February 2, 2015
President's budget acknowledges Alzheimer's disease as unchecked threat but does not meet urgent funding needs
President Barack Obama's fiscal year 2016 budget recognizes the unique threat posed by Alzheimer's, the most expensive disease in the nation and the only leading cause of death in the United States with no way to prevent, stop or even slow its progression, calling for a $51 million increase in Alzheimer's research. However, without increasing funding to the levels deemed necessary by the scientific community, America is unlikely to complete the primary goal of the National Plan to Address Alzheimer's Disease to prevent and effectively treat Alzheimer's disease by 2025.
January 26, 2015
New Alzheimer's Association research grants accelerate studies of potential Alzheimer's drug therapies
The Alzheimer's Association has announced new grant awards for five early-phase clinical trials. The grants are funded through the Alzheimer's Association Part the Cloud Translational Research for Alzheimer's Disease initiative, which supports research critical to transitioning early, exploratory laboratory studies to Phase 1 clinical drug trials in humans. The new awards total nearly $4 million, increasing the total amount awarded through the initiative since its inception to $6 million.
January 14, 2015
Scientists look to heart disease and stroke-related disorders for clues to preventing and treating Alzheimer’s
Recommendations by a group of scientists to bolster research on how Alzheimer’s disease and vascular conditions progress together and influence each other are available online today, in advance of publication, by Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. The authors hope this research agenda, if executed, will uncover new clues for effectively treating or preventing dementia.
December 17, 2014
Alzheimer’s Association advocates celebrate Alzheimer’s legislative victory with an eye to the president’s 2016 budget
As the largest Alzheimer’s advocacy organization in the world, the Alzheimer’s Association, and its relentless advocates, applaud Congress for creating a formal process to ensure that scientific judgment will guide them in future Alzheimer’s research funding decisions. This critical provision comes from the Alzheimer’s Accountability Act, which was fully incorporated within the fiscal year 2015 funding bill signed into law by the president.
December 9, 2014
Efforts of Alzheimer's Association advocates incorporated in funding bill
As the largest Alzheimer's advocacy organization in the world, the Alzheimer's Association commends Congress for addressing Alzheimer's disease in the fiscal year 2015 funding bill released today. By incorporating the Alzheimer's Accountability Act, which was shepherded by the Alzheimer's Association, Congress has made a long-term commitment to elevating research funding to the necessary levels.
November 18, 2014
Consortium aims to jump-start drug development for brain diseases
Drugs for brain diseases such as Alzheimer's, Parkinson's and motor neurone disease that have stalled in development could be revived thanks to the efforts of a global coalition of nonprofit organizations and funders announced today.
November 7, 2014
More than 5 million Americans have a fatal disease, and it's not Ebola
Harry Johns, president and CEO of the Alzheimer's Association, released a statement in reaction to President Barack Obama's request this week for more than $6 billion in additional funding to combat Ebola.
October 24, 2014
New Alzheimer's Association research grants fund multiple investigations of non-drug treatments
While the majority of Alzheimer's disease drug trials are funded by the government and pharmaceutical companies, the Alzheimer's Association is filling a gap in research by funding several new studies of non-drug therapies.
October 21, 2014
Alzheimer's and dementia research leaders join Alzheimer's Association national Medical and Scientific Advisory Council
The Alzheimer's Association announces the addition of five new members to its national Medical and Scientific Advisory Council (MSAC). The MSAC serves in an advisory role for the Alzheimer’s Association research program, including the International Research Grant Program and other strategic scientific initiatives, such as identifying new areas of research that merit further development, with the goal of accelerating scientific progress.
October 20, 2014
Scientists say National Alzheimer's Plan research milestones must be strengthened to meet its primary goal by the 2025 deadline
A workgroup of nearly 40 Alzheimer's researchers and scientists says the research milestones in the U.S. government's National Plan to Address Alzheimer's Disease must be broadened in scope, increased in scale and adequately funded in order to successfully achieve this goal. A series of proposals by the workgroup to enlarge and strengthen the plan are published today in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
July 28, 2014
Senate Appropriations Subcommittee encourages NIH to address research funding for Alzheimer's crisis
In June, the U.S. Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies allocated an additional $100 million in its fiscal year 2015 funding bill for Alzheimer’s research. In the report recently released, the subcommittee also called for the National Institutes of Health (NIH) to submit a Professional Judgment Budget for Alzheimer’s disease research and a report that outlines research conducted on Alzheimer’s disease relative to milestones established under the National Plan to Address Alzheimer’s Disease.
July 23, 2014
World Dementia Council discusses urgent Alzheimer's research and funding needs
World Dementia Council discusses urgent Alzheimer's research and funding needs Harry Johns, president and CEO of the Alzheimer’s Association and newly appointed member of the World Dementia Council, participated in the meeting on behalf of the at least 44 million people worldwide living with dementia, including more than 5 million Americans living with the Alzheimer’s disease, and their caregivers.
July 16, 2014
Alzheimer's drug trial shows cognitive benefits in mild cases of the disease
Phase 2 clinical trial results for crenezumab (Genentech) were presented at AAIC 2014. The drug did not meet its primary endpoints for cognition and activities of daily living, but there was a positive finding in a subgroup of the study population with mild Alzheimer's. The Alzheimer's Association notes that a key learning from the trial is that treating Alzheimer's earlier shows potential for effective treatment and prevention.
July 15, 2014
Alzheimer's caregiver testifies at Senate Committee on Finance hearing about unmet patient needs
Today, before the Senate Committee on Finance, Mary Margaret Lehmann shared her experience providing care for her husband, Ken Lehmann, who is living with Alzheimer's disease.
July 8, 2014
Alzheimer's Association receives $1 million pledge from Sigma Kappa for women's initiative
The Alzheimer's Association has received a $1 million pledge from the Sigma Kappa Foundation for the newly launched Alzheimer's Association Women's Initiative. The gift will fund clinical research focused on women, as well as studies led by female researchers who are working to advance Alzheimer's and dementia science.
June 19, 2014
Nearly 60 percent of people worldwide incorrectly believe that Alzheimer's disease is a typical part of aging
According to an Alzheimer's Association 12-country survey, 59 percent of people surveyed incorrectly believe that Alzheimer's disease is a typical part of aging and 40 percent of people believe that Alzheimer's is not fatal.
June 17, 2014
Alzheimer's Association Journal Compiles Key Research for the First Time on Military Risk Factors for Dementia
Our nation's soldiers and veterans represent a population at elevated risk for dementia and cognitive decline, according to findings published in a special issue of Alzheimer's & Dementia: The Journal of the Alzheimer's Association. Research articles in the special issue cite the circumstances of modern war, the consequences of head injury, post-traumatic stress disorder (PTSD) and other war-related factors as reasons for this increased hazard.
June 10, 2014
Alzheimer's Association applauds inclusion of additional $100 million for Alzheimer's disease in senate funding bill
The U.S. Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies allocated an additional $100 million in its fiscal year 2015 funding bill for Alzheimer's research. The Alzheimer's Association commends Chairman Tom Harkin (D-IA) and Ranking Member Jerry Moran (R-KS) for their ongoing commitment to Alzheimer's.
June 2, 2014
Inaugural Alzheimer's & Brain Awareness Month initiates a global conversation about dementia
During the inaugural Alzheimer's & Brain Awareness Month this June, the Alzheimer's Association is asking people around the world to wear purple — the color of the Alzheimer's movement — and use their brains to fight Alzheimer's disease.
April 2, 2014
Alzheimer's Association applauds the introduction of the Alzheimer's Accountability Act
The Alzheimer's Association applauds introduction of the Alzheimer's Accountability Act, which represents a bipartisan effort to ensure that Congress is equipped with the best possible information to set funding priorities and reach the goal of the National Plan to Address Alzheimer's Disease to prevent and effectively treat Alzheimer's by 2025.
March 27, 2014
Alzheimer's Association, Reagan-Udall Foundation for the FDA launch Alzheimer's disease regulatory science fellowship
The Alzheimer's Association and the Reagan-Udall Foundation (RUF) for the Food and Drug Administration (FDA) are pleased to announce the launch of a new fellowship to allow an experienced physician, dedicated to treating and studying Alzheimer's disease, the opportunity to work collaboratively with the FDA.
March 19, 2014
Women in their 60s twice as likely to develop Alzheimer's disease over the rest of their lives as they are breast cancer
According to the Alzheimer's Association 2014 Alzheimer's Disease Facts and Figures report released today, a woman's estimated lifetime risk of developing Alzheimer's at age 65 is 1 in 6, compared with nearly 1 in 11 for a man. As real a concern as breast cancer is to women's health, women in their 60s are about twice as likely to develop Alzheimer's over the rest of their lives as they are to develop breast cancer.
March 5, 2014
Alzheimer's Association awards largest-ever research grant to expand A4 Alzheimer's prevention trial
The Alzheimer's Association today announced its largest ever research grant — $8 million over four years — to support the Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) study as a companion study to the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Study, a pioneering Alzheimer's prevention trial that is starting this year.
February 26, 2014
Seth Rogen, Dennis Moore testify at Senate Appropriations Subcommittee hearing
The Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies held a hearing dedicated to the economic impact of Alzheimer's disease in America. Chaired by Senators Tom Harkin (D-Iowa) and Jerry Moran (R-Kan.), the hearing also examined the current state of biomedical research into prevention and treatment of the disease. National Institutes of Health (NIH) Director Dr. Francis Collins, former Congressman Dennis Moore (D-Kan.), who is living with Alzheimer's, and Alzheimer's Association celebrity Champion Seth Rogen testified about the importance of funding Alzheimer's research.
February 5, 2014
Groups unite to cross the lines between Alzheimer's and Parkinson's
The Alzheimer's Association, the Michael J. Fox Foundation for Parkinson's Research (MJFF) and the W. Garfield Weston Foundation are uniting to encourage further study into the similarities and differences between Alzheimer's and Parkinson's, the two most common brain diseases.
January 17, 2014
Record $122 million increase for Alzheimer's disease signed into law by President Obama
At the urging of the Alzheimer's Association and its more than 600,000 advocates, the funding bill signed into law today by President Obama contained an unprecedented $122 million increase for Alzheimer's research, education, outreach and caregiver support. The Association applauds the Obama administration for calling for increased Alzheimer's funding in the president's Fiscal Year 2014 budget and Congress for providing funding to enable the continued, effective implementation of the National Plan to Address Alzheimer's Disease.
January 16, 2014
Record $122 million increase for Alzheimer's disease passed by Congress, sent to president
An unprecedented $122 million increase for Alzheimer's research, education, outreach and caregiver support stemming from the efforts of Alzheimer's Association advocates was passed swiftly by Congress today. The Alzheimer's Association commends the bipartisan work of our elected officials to make Alzheimer's disease a national priority.
January 14, 2014
Record $122 million increase proposed for Alzheimer's disease in funding bill
The fiscal year 2014 federal budget funding bill released by bipartisan House and Senate negotiators includes the largest funding increase in history dedicated to Alzheimer's disease and dementia — $122 million for Alzheimer's research, education, outreach and caregiver support.
December 11, 2013
G8 countries collectively agree to goals including mirroring U.S. National Alzheimer's Plan
Alzheimer's Association President and CEO Harry Johns presented at and participated in the first-ever G8 Dementia Summit, where world leaders acknowledged that the Alzheimer's and dementia crisis cannot be ignored.
November, 21, 2013
Former Congressman Dennis Moore named to Advisory Council on Alzheimer's Research, Care and Services
The Alzheimer's Association applauds the Department of Health and Human Services (HHS) on selecting former Congressman Dennis Moore (D-Kan.) to share his perspective on living with Alzheimer's as the newest member of the Advisory Council on Alzheimer's Research, Care, and Services
November, 21, 2013
Alzheimer's Association emphasizes urgency of increased global research effort at Hill briefing
The urgent need for additional research funding for Alzheimer's disease and other dementias worldwide was the core message delivered by representatives of the Alzheimer's Association during testimony today before the House Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations. The hearing was held in anticipation of the upcoming first-ever G8 summit on dementia.
October, 29, 2013
Research grants explore links between Alzheimer's and Down syndrome
The Global Down Syndrome Foundation, the Alzheimer's Association and the Linda Crnic Institute for Down Syndrome have awarded $1.2 million in research grants to five scientists for innovative investigations that explore the development of Alzheimer's disease in individuals with Down syndrome.
October 21, 2013
Alzheimer's Association statement on screening for cognitive impairment in older adults
The Alzheimer's Association supports efforts that increase early detection and diagnosis of Alzheimer's by trained professionals in a medical setting, such as through the Medicare Annual Wellness Visit. The Association does not support one-time memory and/or dementia screening in non-medical settings, such as shopping malls or health fairs.
September 30, 2013
Alzheimer's Association responds to CMS final ruling on coverage of imaging diagnostic tool
The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services (CMS) decision to only allow Coverage with Evidence Development (CED) for an Alzheimer's disease imaging test that would improve diagnostic accuracy and certainty in challenging cases.
September 18, 2013
Alzheimer's Association applauds NIH for awarding $45 million to innovative Alzheimer's research projects
The Alzheimer's Association commends the National Institutes of Health (NIH) for dedicating additional funds to Alzheimer's disease research. Today's announcement was the fulfillment of a $45 million promise made by Dr. Francis Collins, NIH director, to advocates attending the Alzheimer's Association Advocacy Forum in the spring and all those who are impacted by Alzheimer's every day.
July 9, 2013
Alzheimer's Association applauds inclusion of $104 million for Alzheimer's disease in Senate funding bill
Recognizing the personal and financial threat of the Alzheimer's epidemic facing the nation and world, the U.S. Senate Committee on Appropriations voted to provide an additional $104 million in its fiscal year 2014 funding bill for Alzheimer's research, education, outreach and caregiver support.
July 5, 2013
Alzheimer's Association to continue to advocate for coverage of diagnostic tool following CMS announcement
The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services (CMS) draft coverage decision on brain amyloid imaging, particularly given the clear, scientific consensus recommendations provided to CMS by the Association and the Society for Nuclear Medicine and Molecular Imaging (SNMMI) regarding appropriate, limited coverage, only in specific populations.
June 14, 2013
HHS releases 2013 update to the National Alzheimer's Plan Today, the Department of Health and Human Services (HHS) released the National Plan to Address Alzheimer's Disease: 2013 Update. The 2013 Update includes a new timeline for achieving its first goal — prevent and effectively treat Alzheimer's disease by 2025 — and a review of progress over the past year.
April 24, 2013
Senate Aging Committee holds hearing during Alzheimer's Association 25th Advocacy Forum
With more than 900 advocates from all 50 states gathered in nation's capital for the Alzheimer's Association 25th Advocacy Forum, the Senate Aging Committee held a hearing to evaluate progress on implementing the country's first-ever National Plan to Address Alzheimer's Disease.
April 11, 2013
Legislation reintroduced to improve diagnosis of Alzheimer's and strengthen care planning
As the world's leading voluntary health organization in Alzheimer's care, support and research, the Alzheimer's Association applauds the reintroduction of the Health Outcomes, Planning, and Education (HOPE) for Alzheimer's Act.
April 10, 2013
Alzheimer's Association applauds Obama administration for dedication of new resources to Alzheimer's epidemic
The Alzheimer's Association commends the Obama administration for dedicating an additional $100 million within President Barack Obama's FY 2014 budget toward the fight against Alzheimer's and the implementation of the National Plan to Address Alzheimer's Disease. These new resources will be used to fund research, awareness, education and outreach, and caregiver support.
April 2, 2013
Alzheimer's Association applauds White House brain mapping initiative
Harry Johns, president and CEO of the Alzheimer's Association, participated in an event at the White House on the Obama administration's BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative referenced during the State of the Union. "The Alzheimer's Association applauds the president for underscoring the critical need for research to better understand the mysteries of the brain," Johns said.
March 19, 2013
New Alzheimer's Association report reveals 1 in 3 seniors dies with Alzheimer's or another dementia
According to the Alzheimer's Association 2013 Alzheimer's Disease Facts and Figures report released today, one in three seniors dies with Alzheimer's or another dementia in the United States. The new report shows that while deaths from other major diseases, such as heart disease, HIV/AIDS and stroke, continue to experience significant declines, Alzheimer's deaths continue to rise — increasing 68 percent from 2000-2010.
March 14, 2013
Alzheimer's Association CEO represents Alzheimer's community at appropriations subcommittee hearing
At a Subcommittee on Labor, Health and Human Services, Education and Related Agencies Committee on Appropriations hearing. Alzheimer's Association President and CEO Harry Johns outlined the dramatic human suffering caused by Alzheimer's and the enormous strain the disease places on the health care system and the federal budget.
February 13, 2013
President Obama includes Alzheimer's in State of the Union
Last night, President Barack Obama included Alzheimer's disease in his State of the Union address. The Alzheimer's Association applauds the president for underscoring the critical need for medical research and demonstrating that addressing Alzheimer's disease is a national priority.
January 30, 2013
Panel requires additional data about brain amyloid imaging for Alzheimer's disease
The Alzheimer's Association is disappointed that the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) panel does not believe that there is adequate evidence whether or not PET imaging of brain beta amyloid changes health outcomes, and urges the Centers for Medicare & Medicaid Service (CMS) to review the evidence and make a positive determination about coverage.
January 28, 2013
First guidelines published for brain amyloid imaging in Alzheimer's
To provide guidance for physicians, individuals and families affected by Alzheimer's, and the public, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer's Association have jointly published the first criteria for the appropriate use of positron emission tomography (PET) imaging technology to aid in the diagnosis of people with suspected Alzheimer's disease.
December 20, 2012
Recommendations for physicians on how to assess cognition during Medicare Annual Wellness Visit
The Alzheimer's Association released guidance to help health care providers detect cognitive impairment as part of the Medicare Annual Wellness Visit.
November 29, 2012
New grants to fund research to better treat Alzheimer's in people with Down syndrome
The Alzheimer's Association, the Linda Crnic Institute for Down Syndrome and the Global Down Syndrome Foundation today launched a new research initiative to better understand the development of Alzheimer's disease in individuals with Down syndrome and translate the research into improved treatments for people at risk to develop Alzheimer's.
October 25, 2012
Scientist exchange program hopes to advance Alzheimer's disease research
The Alzheimer's Association and Alzheimer's Research UK today announced a pair of new research grants totaling more than $600,000 as part of an international scientific exchange program intended to promote the work of promising young scientists and stimulate the sharing of new experimental techniques across borders.
October 23, 2012
Settlement ensures people with Alzheimer's access to rehabilitative services
As one of the plaintiffs in the federal class action lawsuit Jimmo v. Sebelius, which challenged the Medicare Improvement Standard, the Alzheimer's Association applauds the recently announced proposed settlement. Under the settlement agreement, Medicare will pay for rehabilitative services, such as physical, speech and occupational therapy, if they maintain an individual's current condition or prevent or slow further deterioration and require the skills of a professional. Rehabilitative services are beneficial to helping people with Alzheimer's maintain their current function.
September 21, 2012
World Alzheimer Report Reveals Negative Perceptions About People With Dementia
Seventy-five (75) percent of people with dementia and 64 percent of caregivers believe there are negative associations for those diagnosed with dementia in their countries, according to survey fielded by Alzheimer's Disease International and published today in the World Alzheimer Report 2012: Overcoming the Stigma of Dementia.
World Report 2012
World Report Executive Summary
September 12, 2012
Alzheimer's Association applauds House passage of missing Alzheimer's Disease Patient Alert Program
The Alzheimer's Association applauds passage of H.R. 2800, The Missing Alzheimer's Disease Patient Alert Program Reauthorization Act introduced by Representative Maxine Waters (D-Calif.). The measure, passed today in the House of Representatives, expands important programs that improve the safety of people living with Alzheimer's disease and other dementias.
August 24, 2012
Alzheimer's Association statement on solanezumab Phase 3 results
Eli Lilly and Company announced that two Phase 3 studies of an experimental Alzheimer's drug therapy called solanezumab did not meet their primary endpoints. However, there is new, hopeful and encouraging information in the results. In a secondary pooled analysis of both studies, the drug showed a statistically significant slowing of cognitive decline in people with mild to moderate Alzheimer's disease; the results were driven by people with mild Alzheimer's.
August 1, 2012
Alzheimer's Association commends committee passage of Missing Alzheimer's Disease Patient Alert Program
The Alzheimer's Association lauds passage of H.R. 2800, The Missing Alzheimer's Disease Patient Alert Program Reauthorization Act, which expands important programs that partner with local law enforcement to improve the safety of people living with Alzheimer's disease and other dementias.
July 23, 2012
Alzheimer's Association Statement on Phase 3 Bapineuzumab Study
Results of a Phase 3 study of Bapineuzumab found not to meet anticipated endpoints in carriers of the ApoE4 Alzheimer's risk gene. Results from a second Phase 3 study of this drug, in an additional population of people who carry the ApoE4 gene, as well as people who do not carry the gene, are expected sin the months to come.
July 10, 2012
Alzheimer's Association lauds enactment of the Food and Drug
As the leading care, research and advocacy organization for Alzheimer's disease, the Alzheimer's Association applauds President Obama for signing the Food and Drug Administration Safety and Innovation Act (S. 3187).
July 2, 2012
Revolutionary new project will obtain complete genetic information on the largest group for a single disease - Alzheimer's
The first, pioneering "Big Data" project for Alzheimer's disease was announced today by a visionary new partnership. New research funding from the Alzheimer's Association and the Brin Wojcicki Foundation will enable scientists to obtain whole genome sequences on the largest group of individuals related to a single disease - more than 800 people enrolled in Alzheimer's Disease Neuroimaging Initiative. This new initiative will rapidly create an unprecedented tool for Alzheimer's researchers.
June 21, 2012
Alzheimer's Association Commends House Passage of the Food and Drug Administration Bill
The Alzheimer's Association commends House passage of the House and Senate reconciled version of the Food and Drug and Administration bill. The Alzheimer's Association supports all efforts to ensure the FDA has the resources it needs to expedite the drug review process for life-threatening diseases.
April 23, 2012
Alzheimer's Association to honor legendary University of Tennessee Lady Vols Head Coach Emeritus Pat Summitt and son Tyler at National Alzheimer's Dinner
Alzheimer's Association will present University of Tennessee Women's Basketball Head Coach Emeritus Pat Summitt and her son, Tyler Summitt, with its Sargent and Eunice Shriver Profiles in Dignity Award at the Alzheimer's Association National Dinner on Tuesday, April 24.
April 17, 2012
Alzheimer's Advisory Council approves its recommendations for National Alzheimer's Plan
During an in-person meeting of the Alzheimer's Advisory Council, members approved a comprehensive set of recommendations that would, if accepted by the Department of Health and Human Services (HHS), complement the important strategies and action steps included in the current draft of the first-ever National Alzheimer's Plan.
April 11, 2012
Alzheimer's Association commends recognition of Alzheimer's and dementia as global health threat
The Alzheimer's Association strongly supports the call to action in the newly released World Health Organization (WHO) report Dementia: A Public Health Priority, which asks for all nations to develop and implement a national Alzheimer's plan, conduct greater efforts in early detection and diagnosis, and increase support of Alzheimer's disease research.
April 6, 2012
Alzheimer's Association statement on FDA approval of florbetapir (Amyvid)
AVID Radiopharmaceuticals, a subsidiary of Eli Lilly and Company, today announced U.S. Food and Drug Administration (FDA) approval of florbetapir (Amyvid), its radioactive dye for use with positron emission tomography (PET) for visualization of amyloid plaque buildup in the brain.
March 20, 2012
Alzheimer's Association awards largest-ever research grant to the Dominantly Inherited Alzheimer's Network (DIAN)
The Alzheimer's Association announced today the awarding of its largest-ever research grant — nearly $4.2 million over four years — to the Dominantly Inherited Alzheimer's Network-Therapeutic Trials Unit (DIAN-TTU), based at Washington University School of Medicine in St. Louis. The grant will enable the program to move forward more quickly with innovative drug and biomarker trials in people with genetically based, young-onset Alzheimer's disease.
March 15, 2012
Alzheimer's advisory council discusses initial draft of National Alzheimer's Plan
The During a conference call meeting among members of the Advisory Council on Alzheimer's Research, Care, and Services and Health and Human Services (HHS) officials, a robust discussion took place as progress toward the development of the country's first-ever National Alzheimer's Plan continued.
March 8, 2012
New report says Alzheimer's and dementia costs to the nation reach $200 billion
According to 2012 Alzheimer's Disease Facts and Figures, released today by the Alzheimer's Association, caring for people with Alzheimer's and other dementias will cost the United States an estimated $200 billion in 2012.
February 22, 2012
Health and Human Services releases National Alzheimer's Plan draft
The release of the first draft of the National Alzheimer's Plan is another positive step toward the nation's first-ever strategic plan for Alzheimer's. Comprehensive in scope, the draft plan addresses issues that are important to the Alzheimer's community including developing new treatments that prevent and effectively treat the disease, delivering much needed support for families, and enhancing care quality and effectiveness.
February 15, 2012
Alzheimer's Association commends Obama administration for recognizing Alzheimer's risk
The Alzheimer's Association commends the Obama administration for releasing a budget that directs needed resources as a down payment in the fight against Alzheimer's disease.
February 7, 2012
Alzheimer's Association commends Obama administration for dedication of new resources to Alzheimer's
The Alzheimer's Association commends the Obama administration for dedicating new resources in the fight against Alzheimer's in a uniquely challenging fiscal year in advance of the first-ever National Alzheimer's Plan.
January 18, 2012
Advisory Council discusses significant recommendations for National Alzheimer's Plan
The Advisory Council on Alzheimer's Research, Care and Services met this week in Washington, D.C., for the second time to discuss the goals and strategies of the National Alzheimer's Plan. The Department of Health and Human Services also outlined its timetable for the plan, with the first blueprint targeted for mid-February and a final plan unveiled in April.
January 9, 2012
Alzheimer's Association®statement on draft framework of National Alzheimer's Plan
The Alzheimer's Association believes the Draft Framework for the National Plan to Address Alzheimer's Disease released today by the Department of Health and Human Services offers a comprehensive outline of goals and strategies that must be addressed in the nation's first-ever strategic plan for Alzheimer's.